Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000245530

Medchemexpress LLC (E/Z)-Afatinib | 439081-18-2 | MFCD12407405 | 100.0% | 485.94 | C24H25ClFN5O3 | 1 ML
SDP

Catalog No. 5000245530
Encompass_Preferred

(E/Z)-Afatinib is a research-grade mixture of the E and Z isomers of Afatinib, an irreversible inhibitor of epidermal growth factor receptor (EGFR) family kinases. It is intended for laboratory research use and is supplied as a concentrated solution for biochemical and cell-based assays.

  • Irreversibly inhibits EGFR, HER2, and HER4.
  • Mixture of E and Z isomers for comprehensive activity profiling.
  • Provided as a 10 mM solution in DMSO, 1 mL, suitable for stock preparation.
  • High purity (99.98% by HPLC) suitable for biochemical assays.
  • Accompanied by datasheet, certificate of analysis, and safety data sheet.

Catalog No. 50-002-45530 Supplier Medchemexpress LLC Supplier No. HY10261B10MM 1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

(E/Z)-Afatinib is a research-grade mixture of the E and Z isomers of Afatinib, an irreversible inhibitor of epidermal growth factor receptor (EGFR) family kinases. It is intended for laboratory research use and is supplied as a concentrated solution for biochemical and cell-based assays.

  • Irreversibly inhibits EGFR, HER2, and HER4.
  • Mixture of E and Z isomers for comprehensive activity profiling.
  • Provided as a 10 mM solution in DMSO, 1 mL, suitable for stock preparation.
  • High purity (99.98% by HPLC) suitable for biochemical assays.
  • Accompanied by datasheet, certificate of analysis, and safety data sheet.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.